BRIEF published on 07/19/2024 at 12:25, 1 year 4 months ago Yellow Cake PLC Reports Impressive Annual Financial Results for March 2024 Financial Highlights Annual Results Yellow Cake PLC Uranium Prices U3O8 Holdings
BRIEF published on 07/19/2024 at 12:25, 1 year 4 months ago Yellow Cake PLC publie des résultats financiers annuels impressionnants pour mars 2024 Résultats Annuels Faits Saillants Financiers Gâteau Jaune PLC Prix De L'uranium Titres En U3O8
PRESS RELEASE published on 07/19/2024 at 12:20, 1 year 4 months ago Yellow Cake PLC: Annual Results for the year ended 31 March 2024 Yellow Cake PLC reports strong annual results for the year ended 31 March 2024, with net asset value reaching USD1,883.6 million. CEO remains confident in strategy amidst rising uranium prices and supply-demand dynamics Net Asset Value Annual Results Yellow Cake PLC Uranium Price Supply-demand Dynamics
Published on 12/05/2025 at 02:35, 4 hours 56 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 31 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 26 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 31 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 31 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 1 minute ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 40 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 6 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 16 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 16 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 31 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 31 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 46 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 46 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
